{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:16:25Z","timestamp":1780496185895,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.diagmicrobio.2020.115117","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T20:07:03Z","timestamp":1592683623000},"page":"115117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae"],"prefix":"10.1016","volume":"98","author":[{"given":"Justin A.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Kulengowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0005","series-title":"Aminoglycoside susceptibility testing breakpoint re-evaluations: updates based on the application of pharmacokinetics\u2013pharmacodynamics and contemporary microbiology surveillance data","author":"Bhavnani","year":"2016"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0010","doi-asserted-by":"crossref","unstructured":"Bhavnani S, Onufrak N, Hammel J, Andes D, Bradley J, Flamm R, et al. Re-appraisal of aminoglycoside (AG) susceptibility testing breakpoints based on the application of pharmacokinetics-pharmacodynamics (PK-PD) and contemporary microbiology surveillance data. IDWeek, October 3\u20137, San Francisco, CA, Poster No. 2562, 2018.","DOI":"10.1093\/ofid\/ofy209.170"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2018.10.023","article-title":"In vitro activity of plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in U.S. Census divisions","volume":"94","author":"Castanheira","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0020","first-page":"3346","article-title":"Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms","volume":"73","author":"Castanheira","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0025","series-title":"Fluoroquinolone breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa: CLSI rationale document MR02","author":"Chantell","year":"2019"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0030","series-title":"Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M100","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect Dis Clin NA"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0040","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0045","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/AAC.00869-16","article-title":"Association between the presence of aminoglycoside-modifying enzymes and in vitro activity of gentamicin, tobramycin, amikacin, and plazomicin against Klebsiella pneumoniae carbapenemase\u2013 and extended-spectrum-\u03b2-lactamase\u2013producing Enterobacter species","volume":"60","author":"Haidar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.diagmicrobio.2018.06.013","article-title":"Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL- and KPC-producing Enterobacter cloacae","volume":"92","author":"Kulengowski","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis. [Internet]"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jac\/dkq408","article-title":"Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates","volume":"66","author":"Livermore","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.diagmicrobio.2017.11.004","article-title":"Antimicrobial activity of plazomicin against Enterobacteriaceae producing carbapenemases from 50 Brazilian medical centers","volume":"90","author":"Martins","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ja.2017.117","article-title":"Destination of aminoglycoside antibiotics in the \u201cpost-antibiotic era.\u201d","volume":"71","author":"Takahashi","year":"2018","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0070","author":"The United States Committee on Antimicrobial Susceptibility Testing (USCAST)"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0075","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1093\/jac\/dkq210","article-title":"A simple phenotypic method for the differentiation of metallo-betalactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates","volume":"65","author":"Tsakris","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0080","series-title":"Plazomicin\u2013injection","author":"U.S. Food and Drug Administration","year":"2019"},{"key":"10.1016\/j.diagmicrobio.2020.115117_bb0085","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/jac\/dkx261","article-title":"In vitro activity of plazomicin against \u03b2-lactamase\u2013producing carbapenem-resistant Enterobacteriaceae (CRE)","volume":"72","author":"Zhang","year":"2017","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320304946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320304946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:55:02Z","timestamp":1760003702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889320304946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0732889320304946"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115117","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115117"}}